Atorvastatin in the treatment of nonalcoholic steatohepatitis

Kanzo/Acta Hepatologica Japonica

Volumn 46, Issue 5, 2005, Pages 292-293

  Hyogo, H ^a   Iwamoto, K ^a   Arihiro, K ^a   Ajima, T ^b   Ishitobi, T ^b   Inoue, M ^b   Ogi, M ^b   Nabeshima, Y ^b   Nonaka, M ^b   Komichi, D ^b   Kobuke, T ^b   Yamaguchi, A ^b   Numata, Y ^b   Nishioka, T ^b   Chayama, K ^b   Tazuma, S ^a  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Atorvastatin; HMG CoA reductase inhibitor; Nonalcoholic steatohepatitis

Indexed keywords

ADIPOCYTOKINE; ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASCORBIC ACID; ATORVASTATIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SILYMARIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; DRUG EFFICACY; EXERCISE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER;

EID: 21144446443     PISSN: 04514203     EISSN: None     Source Type: Journal    
DOI: 10.2957/kanzo.46.292     Document Type: Article

References (5)

1. Ludwig J, Viggiano TR, McGill DB, et al. Mayo Clin Proc 1980; 55: 434-8
2. Shimada M, Hashimoto E, Taniai M, et al. J Hepatol 2002; 37: 154-60
3. Inoue I, Itoh F, Aoyagi S, et al. Biochem Biophys Res Com 2002; 290: 131-9
4. Horlander JC, Kwo PY. Gastroenterology 2001; A544
5. Kiyici M, Gulten M, Gurel S, et al. Can J Gastroenterol 2003; 17: 713-8